Jane Street Group, LLC Alkermes Plc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$23.07 - $27.99 $55,368 - $67,176	-2,400 Reduced 10.81%	19,800 $521,000
Q4 2021 Feb 15, 2022	BUY	$21.47 - $32.08 $45,087 - $67,368	2,100 Added 10.45%	22,200 $516,000
Q3 2021 Nov 16, 2021	SELL	$23.37 - $32.13 $292,125 - $401,625	-12,500 Reduced 38.34%	20,100 $620,000
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $1.27 Million - $1.7 Million	-67,400 Reduced 67.4%	32,600 $799,000
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $1.31 Million - $2.12 Million	100,000 New	100,000 $1.44 Million

360

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.